AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 100 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $18 | -78.3% | 15,094 | -89.8% | 0.00% | -100.0% |
| Q1 2023 | $83 | -98.8% | 148,681 | +534.0% | 0.00% | – |
| Q3 2022 | $7,000 | -98.2% | 23,453 | -97.9% | 0.00% | -100.0% |
| Q2 2022 | $389,000 | +2061.1% | 1,103,737 | +4268.1% | 0.00% | – |
| Q1 2022 | $18,000 | -97.9% | 25,268 | -93.3% | 0.00% | -100.0% |
| Q4 2021 | $855,000 | +262.3% | 378,568 | +506.2% | 0.01% | +150.0% |
| Q2 2021 | $236,000 | -73.6% | 62,446 | -76.3% | 0.00% | -77.8% |
| Q1 2021 | $893,000 | +1295.3% | 263,981 | +1512.9% | 0.01% | +200.0% |
| Q3 2019 | $64,000 | – | 16,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
| DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
| Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
| Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
| Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
| Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
| Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
| Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
| KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
| Leap Investments LP | 54,700 | $415,000 | 0.61% |